Patients being considered for transcatheter aortic valve replacement (TAVR) are frequently
diagnosed with coronary artery disease. In patients requiring revascularization, there is a …

Background Despite transcatheter aortic valve implantation (TAVI) becoming a widely
accepted therapeutic option for the management of aortic stenosis, post-procedure …

BACKGROUND Data on trends, predictors, and outcomes of heart failure (HF) readmissions
after transcatheter aortic valve replacement (TAVR) remain limited. Moreover, the …

Aims Despite aortic stenosis (AS) relief, patients undergoing transcatheter aortic valve
implantation (TAVI) are at increased risk of developing heart failure (HF) within first months …

Aims To assess gender differences in in-hospital mortality and 90-day readmission rates
among patients undergoing transcatheter aortic valve replacement (TAVR) in the USA …

Background There is a paucity of data on the feasibility of same‐day discharge (SDD)
following transcatheter aortic valve implantation (TAVI) at a national level. Methods and …

Type 2 myocardial infarction (Type 2 MI) is a common problem and carries a high diagnostic
uncertainty. Large studies exploring outcomes in type 2 MI are lacking. Nationwide …

As transcatheter aortic valve implantation (TAVI) continues its rapid growth as a treatment
approach for aortic stenosis, costs associated with TAVI, and its burden to healthcare …

Transcatheter aortic valve replacement (TAVR) is the treatment of choice for patients with
severe aortic stenosis across the spectrum of surgical risk. About one-third of 30-day …

Aims Usage of transcatheter aortic valve implantation (TAVI) for treatment of severe aortic
stenosis is increasing across age groups. However, literature on age-specific TAVI …